SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000819050-20-000193
Filing Date
2020-09-01
Accepted
2020-09-01 08:31:29
Documents
17
Period of Report
2020-08-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bbi-20200831.htm   iXBRL 8-K 66469
2 EX-3.1 a202008318kexhibit31.htm EX-3.1 13618
3 EX-3.2 a202008318kexhibit32.htm EX-3.2 32836
4 EX-10.1 a202008318kexhibit101.htm EX-10.1 185267
  Complete submission text file 0000819050-20-000193.txt   485572

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bbi-20200831.xsd EX-101.SCH 2428
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bbi-20200831_cal.xml EX-101.CAL 719
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bbi-20200831_def.xml EX-101.DEF 1656
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bbi-20200831_lab.xml EX-101.LAB 26305
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bbi-20200831_pre.xml EX-101.PRE 13740
10 EXTRACTED XBRL INSTANCE DOCUMENT bbi-20200831_htm.xml XML 11673
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21088 | Film No.: 201153350
SIC: 2836 Biological Products, (No Diagnostic Substances)